MedTrace Logo

Redox Determinants of Severe Asthma (a Substudy of the Severe Asthma Research Program)

NCT00590005 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 225

Last updated 2014-02-10

Study results available
· View outcomes & findings →

Summary

Hypotheses: 1) Airway pH regulation is abnormal in severe asthma; 2) In severe asthma, there is formation of cytotoxic nitrogen oxides and loss of beneficial nitrogen oxides in the airways

Conditions

Sponsors & Collaborators

  • The Cleveland Clinic

    collaborator OTHER

  • Emory University

    lead OTHER

Principal Investigators

  • W G Teague, MD · University of Virginia

Eligibility

Min Age
6 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00590005 on ClinicalTrials.gov